Gary Ingenito

Track

Insider profile

Currently holds a position at Catalyst Pharmaceuticals Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
18 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Catalyst Pharmaceuticals Inc June 30, 2015 -
Gary Ingenito's trades of Catalyst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
124.98
Quantity 97,657
Value US$3,976,578
Transaction date
Proposed sale
Price
23.98
Quantity 200,000
Value US$4,796,000
Transaction date
Proposed sale
Price
21.67
Quantity 180,096
Value US$3,903,251
Transaction date
Proposed sale
Price
18.03
Quantity 100,000
Value US$1,803,262
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-15 2025-05-14
S Sale
17,157 -4.6%
116.01
US$2,288,052 		17,157 -4.6% 116.01 US$2,288,052
2025-05-14 2025-05-14
PrS Proposed sale
97,657
124.98
US$3,976,578 		97,657 124.98 US$3,976,578
2025-05-15 2025-05-13
S Sale
4,323 -42.6%
338.98
US$682,083 		4,323 -42.6% 338.98 US$682,083
2025-05-13 2025-05-13
PrS Proposed sale
200,000
23.98
US$4,796,000 		200,000 23.98 US$4,796,000
2025-03-07 2025-03-06
S Sale
180,096 -72.3%
21.67
US$3,902,680 		180,096 -72.3% 21.67 US$3,902,680
2025-03-06 2025-03-06
PrS Proposed sale
180,096
21.67
US$3,903,251 		180,096 21.67 US$3,903,251
2025-03-07 2025-03-05
S Sale
44,904 -39.5%
22.09
US$991,929 		44,904 -39.5% 22.09 US$991,929
2025-03-05 2025-03-05
PrS Proposed sale
44,904
22.09
US$991,911 		44,904 22.09 US$991,911
2024-11-29 2024-11-27
S Sale
3,369 -6.2%
22.67
US$76,385 		3,369 -6.2% 22.67 US$76,385
2024-11-29 2024-11-27
S Sale
8,631 -13.6%
22.74
US$196,269 		8,631 -13.6% 22.74 US$196,269
2024-11-27 2024-11-27
PrS Proposed sale
12,000
22.72
US$272,653 		12,000 22.72 US$272,653
2024-11-22 2024-11-20
S Sale
38,000 -42.5%
21.20
US$805,562 		38,000 -42.5% 21.20 US$805,562
2024-11-20 2024-11-20
PrS Proposed sale
38,000
21.20
US$805,543 		38,000 21.20 US$805,543
2024-08-13 2024-08-09
S Sale
100,000 -66.1%
18.04
US$1,804,000 		100,000 -66.1% 18.04 US$1,804,000
2024-08-09 2024-08-09
PrS Proposed sale
100,000
18.03
US$1,803,262 		100,000 18.03 US$1,803,262
2024-06-07 2024-06-05
S Sale
80,000 -60.9%
16.16
US$1,292,800 		80,000 -60.9% 16.16 US$1,292,800
2024-06-05 2024-06-05
PrS Proposed sale
80,000
16.16
US$1,292,976 		80,000 16.16 US$1,292,976
2023-12-08 2023-12-06
S Sale
50,000 -56.6%
14.02
US$701,000 		50,000 -56.6% 14.02 US$701,000
2023-12-06 2023-12-06
PrS Proposed sale
50,000
14.27
US$713,500 		50,000 14.27 US$713,500
2022-12-08 2022-12-06
S Sale
5,918 -16.1%
16.85
US$99,718 		5,918 -16.1% 16.85 US$99,718
2022-09-16 2022-09-14
S Sale
88,000 -80.0%
15.69
US$1,380,544 		88,000 -80.0% 15.69 US$1,380,544
2022-09-16 2022-09-14
S Sale
55,000 -71.4%
15.65
US$860,915 		55,000 -71.4% 15.65 US$860,915
2022-06-23 2022-06-22
S Sale
6,152 -21.8%
6.61
US$40,646 		6,152 -21.8% 6.61 US$40,646
2022-06-23 2022-06-21
S Sale
143,848 -86.7%
6.60
US$948,678 		143,848 -86.7% 6.60 US$948,678
2021-12-08 2021-12-07
S Sale
3,612 -14.1%
6.99
US$25,237 		3,612 -14.1% 6.99 US$25,237
2020-12-28 2020-12-22
S Sale
3,668 -25.0%
3.45
US$12,644 		3,668 -25.0% 3.45 US$12,644
2019-11-27 2019-11-27
S Sale
100,000 -100.0%
4.66
US$466,000 		100,000 -100.0% 4.66 US$466,000